secoisolariciresinol Report issue

Botanical Experimental
AACT DrugBank MeSH PubChem

Active Ingredient History

NOW
  • Now
Secoisolariciresinol is an organic compound. It is classified as a lignan, i.e., a type of phenylpropanoid. It is present in some cereals, such as rye, and together with matairesinol has attracted much attention for its beneficial nutritional effects.   Wikipedia

Chemistry

More Chemistry

Pharmacology

  • Mechanisms of Action:
  • Multi-specific: Missing data
  • Black Box: Missing data
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: Missing data

Alternative names

2,3-bis(3-methoxy-4-hydroxybenzyl)butane-1,4-diol 1,4-diglucoside | 2,3-bis((4-hydroxy-3-methoxyphenyl)methyl)-1,4-butanediol | bmhb-diglc | eviendep | knotolan | secoisolariciresinol | secoisolariciresinol diglucoside | secoisolariciresinol, (r*,s*)-isomer

Organizations (8)

Research & Development (8)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (9)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (9)


 

Adenocarcinoma (Phase 1/Phase 2)

Aging (Phase 2)

Breast Neoplasms (Phase 2)

Dementia (Phase 2)

Diabetes Mellitus, Type 2 (Phase 2)

Hypercholesterolemia (Phase 2)

Inflammation (Phase 2)

Oxidative Stress (Phase 2)

Pain (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 6
  • # of Trial Organizations: 8

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue